O'Rourke v. Tiffany and Company

CourtDistrict Court, D. Rhode Island
DecidedMarch 27, 2020
Docket1:16-cv-00626
StatusUnknown

This text of O'Rourke v. Tiffany and Company (O'Rourke v. Tiffany and Company) is published on Counsel Stack Legal Research, covering District Court, D. Rhode Island primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
O'Rourke v. Tiffany and Company, (D.R.I. 2020).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF RHODE ISLAND

___________________________________ ) LISA M. O’ROURKE ) ) Plaintiff, ) ) v. ) C.A. No. 16-626 WES ) TIFFANY AND COMPANY, ) ) Defendant. ) ___________________________________)

MEMORANDUM AND ORDER

WILLIAM E. SMITH, District Judge. This employment discrimination action stems from the termination of Plaintiff Lisa M. O’Rourke from Defendant Tiffany and Company (“Tiffany”). Currently before the Court is Defendant’s Motion for Summary Judgment, ECF No. 34. Defendant argues that it is entitled to summary judgment on all three claims advanced by Plaintiff in the Amended Complaint (“Am. Compl.”), ECF No. 32. For the reasons that follow, Defendant’s Motion for Summary Judgment is GRANTED. I. Background and Travel Plaintiff began her employment with Tiffany in 2010 at its manufacturing facility in Cumberland, Rhode Island. Def.’s Statement of Undisputed Facts (“Def.’s SUF”) ¶ 1, ECF No. 35. By 2014, Plaintiff was promoted to Director of Purchasing and Planning, in which capacity she supervised nineteen employees and performed purchasing, planning, and sourcing duties. Id. ¶¶ 2-3. While in that position, Plaintiff reported to the Group Director of Purchasing and Planning, Mary Messier. Id. ¶ 4.

A. BRCA2 Diagnosis and First Leave Three years after beginning her employment at Tiffany, Plaintiff learned that she was a carrier of the BRCA2 gene mutation.1 Id. ¶ 15. To mitigate the risk associated with being a carrier of that gene mutation, Plaintiff underwent two surgeries in the early part of 2014, for which she took a leave of absence from Tiffany (“First Leave”). Id. ¶ 16. Plaintiff’s First Leave lasted seventeen weeks, from January 13, 2014, through May 12, 2014. Id. The first twelve weeks of that leave were covered under the Family Medical Leave Act (“FMLA”), 29 U.S.C. § 2601, et seq. Plaintiff and Messier had a friendly relationship while they worked together at Tiffany and kept in contact during Plaintiff’s

First Leave. Id. ¶ 18. According to her deposition testimony, at some point during the First Leave, Plaintiff felt some pressure from Messier to return to work after Messier brought up another

1 Mutations of the BRCA2 gene correlate with an increased risk of certain cancers, namely breast and ovarian cancer. Such mutations are often hereditary. A mutation of the BRCA2 gene is not a cancer diagnosis, nor does it mean that the patient will ultimately develop cancer; it indicates only that the patient has a higher-than-average risk of developing cancer. See BRCA gene test for breast and ovarian cancer risk, Mayo Clinic, https://www.mayoclinic.org/tests-procedures/brca-gene- test/about/pac-20384815 (last visited March 26, 2020). Tiffany employee who underwent a similar procedure and had returned to work. Id. Plaintiff reached out to a colleague about these concerns, and ultimately determined that she may have been

“overthink[ing]” her conversation with Messier. Id. ¶ 19. Additionally, while Plaintiff was out on her First Leave, Tiffany hired Wayne Howard (“Howard”) to serve as Vice President of Manufacturing, a position two levels above Plaintiff’s position.2 Id. ¶¶ 7, 9. Howard began his tenure with the company in January 2014, and in his role managed 800 to 900 employees scattered across Tiffany’s various manufacturing facilities.3 Id. ¶¶ 7-8. Howard was aware that Plaintiff had taken a leave of absence for medical reasons. Plaintiff’s Statement of Disputed Facts/Obj. to Def.’s Statement of Undisputed Facts (“Pl.’s SDF”) ¶ 26, ECF No. 39-1; see Def.’s SUF Ex. K, at 2, ECF No. 35-11. B. Return to Work after First Leave and 2013 Performance

Evaluation Plaintiff returned to work in May 2014 without any medical restrictions or accommodations. Def.’s SUF ¶ 28. Not long after her return, Plaintiff hired a new employee, Ricky Martin, to fill a position under her supervision which had been vacant for over a year. Id. ¶ 33. Martin quit just two weeks after he started,

2 Messier reported directly to Howard. Def.’s SUF ¶ 9. 3 According to Plaintiff, she had minimal, monthly interaction with Howard, rarely face-to-face. Id. ¶ 10. leaving “negative feedback” about Plaintiff upon his exit. Id. ¶ 34; Pl.’s SDF ¶ 34. Soon thereafter, in June 2014, Howard began to question

Plaintiff’s performance. Def.’s SUF ¶¶ 35-36. Part of Howard’s concern stemmed from the circumstances of Martin’s departure. Id. ¶ 34; Pl.’s SDF ¶ 34. Additionally, Howard identified Tiffany’s planning function, overseen by Messier and Plaintiff, to be an area of weakness for the company. Def.’s SUF ¶ 30. Howard’s concerns came to light through discussion of Plaintiff’s 2013 performance review in an email to his supervisor on June 10, 2014.4 Id. ¶ 36. The email reads, in pertinent part: Lisa was out on medical leave since I started, only returning the week that you, Ralph and I went to [Tiffany’s Rhode Island facility]. Based on [Messier’s] review, she rated Lisa as a 5, for 2013 and recommended relevant bonus and increase when we were doing performance reviews.

I haven ‘t [sic] worked with Lisa yet, but based on what we have seen with planning, and the recent quick turnover of Ricky Martin, there are issues in my mind. However, I wasn’t here in 2013 so I don’t want to be unfair, and planned to evaluate her performance over the next few

4 Tiffany uses a yearly two-level performance evaluation system in which each employee is initially evaluated by his or her direct supervisor and rated on a scale of one to six, where “1” signifies “unsatisfactory” performance and “6” signifies “outstanding” performance. Def.’s SUF Ex. B, at 46, ECF No. 35- 2. That evaluation is then passed up to another supervisor, who determines whether the initial evaluation needs to be adjusted to account for any perceived performance issues. See Def.’s SUF ¶¶ 68-70. Supervisor evaluation scores are one of several data inputs that influence an employee’s annual bonus and merit raise increase. See id. ¶¶ 133-141. months. Unfortunately, I heard last week that she will be out again in July for up to 6 weeks.

So, my thought was to sign the forms and speak to [Messier] about carefully evaluating her performance.

Def.’s SUF Ex. K, at 2. Despite Howard’s questions, Plaintiff received an evaluation score of “5”5 for the calendar year 2013 and 100% of the bonus for which she was eligible that year. Def.’s SUF ¶¶ 42, 138. C. Plaintiff’s Second Leave In July 2014, Plaintiff planned to take another leave from Tiffany for follow-up reconstructive surgery. Id. ¶ 43. Around July 10, 2014, Plaintiff put in a request with Tiffany’s third- party leave administrator, Matrix Absence Management (“Matrix”). Id. ¶ 44. Matrix denied Plaintiff’s leave request because she had exhausted her FMLA entitlement for the year during her First Leave. Def.’s SUF Ex. M, ECF No. 35-13. Former Tiffany Human Resources Manager Karen Curtis discussed the denial with Plaintiff and suggested that Plaintiff could use vacation time or reschedule her procedure to ensure that her job was protected. Def.’s SUF ¶ 46; Def.’s SUF Ex. I, at 27:8-13, ECF No. 35-9; Pl.’s SDF ¶ 46. Plaintiff declined that suggestion because she planned to use her vacation time later that year for a family trip. Def.’s SUF ¶ 47. After speaking with Curtis and following up with Messier,

5 A “5” rating under Tiffany’s metrics means that the employee “frequently exceeded expectations.” Def.’s SUF ¶ 67. Plaintiff contacted Philip Gajdjis, Senior Director of Human Resources, Jewelry and Diamond Supply. Id. ¶¶ 48-49. Plaintiff discussed with Gajdjis her belief that she was being treated

differently than another manufacturing employee whose leave had been approved when that employee had already exhausted the FMLA entitlement. Id. ¶ 49.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
St. Mary's Honor Center v. Hicks
509 U.S. 502 (Supreme Court, 1993)
Smith v. Stratus Computer, Inc.
40 F.3d 11 (First Circuit, 1994)
Hodgens v. General Dynamics Corp.
144 F.3d 151 (First Circuit, 1998)
Mulvihill v. Top-Flite Golf Co.
335 F.3d 15 (First Circuit, 2003)
Webber v. International Paper Co.
417 F.3d 229 (First Circuit, 2005)
Ruiz Rivera v. PEIZER PHARMACEUTICALS, LLC
521 F.3d 76 (First Circuit, 2008)
Samuel Mesnick v. General Electric Company
950 F.2d 816 (First Circuit, 1991)
Valdez v. McGill
462 F. App'x 814 (Tenth Circuit, 2012)
Acevedo-Parrilla v. Novartis Ex-Lax, Inc.
696 F.3d 128 (First Circuit, 2012)
Bennett v. Saint-Gobain Corp.
507 F.3d 23 (First Circuit, 2007)
Carrero-Ojeda v. Autoridad de Energia Electrica
755 F.3d 711 (First Circuit, 2014)
William Tennial v. United Parcel Serv.
840 F.3d 292 (Sixth Circuit, 2016)
Chase v. United States Postal Service
843 F.3d 553 (First Circuit, 2016)
Cherkaoui v. City of Quincy
877 F.3d 14 (First Circuit, 2017)
Miceli v. JetBlue Airways Corp.
914 F.3d 73 (First Circuit, 2019)
Flaherty v. Entergy Nuclear Operations Inc
946 F.3d 41 (First Circuit, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
O'Rourke v. Tiffany and Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/orourke-v-tiffany-and-company-rid-2020.